- Home
- SGHT vs RPID Comparison
SGHT vs RPID Comparison
Compare SGHT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- RPID
- Stock Information
- Founded
- SGHT 2011
- RPID 2006
- Country
- SGHT United States
- RPID United States
- Employees
- SGHT N/A
- RPID N/A
- Industry
- SGHT Medical Specialities
- RPID Medical Specialities
- Sector
- SGHT Health Care
- RPID Health Care
- Exchange
- SGHT Nasdaq
- RPID Nasdaq
- Market Cap
- SGHT 193.2M
- RPID 154.7M
- IPO Year
- SGHT 2021
- RPID 2021
- Fundamental
- Price
- SGHT $5.24
- RPID $2.93
- Analyst Decision
- SGHT Buy
- RPID Strong Buy
- Analyst Count
- SGHT 8
- RPID 2
- Target Price
- SGHT $4.50
- RPID $8.00
- AVG Volume (30 Days)
- SGHT 221.6K
- RPID 88.7K
- Earning Date
- SGHT 11-06-2025
- RPID 11-14-2025
- Dividend Yield
- SGHT N/A
- RPID N/A
- EPS Growth
- SGHT N/A
- RPID N/A
- EPS
- SGHT N/A
- RPID N/A
- Revenue
- SGHT $76,303,000.00
- RPID $30,289,000.00
- Revenue This Year
- SGHT N/A
- RPID $16.63
- Revenue Next Year
- SGHT $12.04
- RPID $21.98
- P/E Ratio
- SGHT N/A
- RPID N/A
- Revenue Growth
- SGHT N/A
- RPID 22.57
- 52 Week Low
- SGHT $2.03
- RPID $0.87
- 52 Week High
- SGHT $5.52
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- SGHT 76.45
- RPID 43.64
- Support Level
- SGHT $3.22
- RPID $2.76
- Resistance Level
- SGHT $5.32
- RPID $3.23
- Average True Range (ATR)
- SGHT 0.31
- RPID 0.27
- MACD
- SGHT 0.22
- RPID -0.07
- Stochastic Oscillator
- SGHT 93.93
- RPID 17.15
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.